Key result
A universal heparin strategy during intra-aortic balloon counterpulsation was associated with increased odds of major limb ischemia or any major bleeding compared to selective heparin (OR 3.32, P=0.03).
Why the study?
Does a universal heparin strategy reduce complications or increase bleeding compared to a selective heparin strategy in patients undergoing IABP in the CCU?
Cohort (n=252)
Does a universal heparin strategy reduce complications or increase bleeding compared to a selective heparin strategy in patients undergoing IABP in the CCU?
Odds Ratio: 3.32
p-value: p=0.03
A selective heparin strategy during IABP in the CCU is associated with less major bleeding compared to universal heparin use, without increasing major IABP-related complications.
No takes yet. Share an insight, caveat, or question.
Suggests selective heparin during IABP may reduce complications; leaves open need for randomized confirmation.
Cooper et al. (2008) conducted a cohort in Patients undergoing intra-aortic balloon counterpulsation (n=252). Universal heparin strategy vs. Selective heparin strategy was evaluated on Major limb ischemia or any major bleeding (OR 3.32, p=0.03). A universal heparin strategy during intra-aortic balloon counterpulsation was associated with increased odds of major limb ischemia or any major bleeding compared to selective heparin (OR 3.32, P=0.03).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: